Search

everythinglearnresearchcommunity

for

Search:↓

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Altered hypothalamic activity may contribute to stress in alopecia areata patients.

Hairless mice are more vulnerable to Listeria infection, but gut microbiota can help reduce damage.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

Microstimulation of certain facial and mouth nerves can evoke specific sensations, while deeper nerves may require multiple stimulations to affect perception.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Sensory neuron remodeling and Merkel-cell changes happen independently during skin maintenance.

Special astrocytes improved learning and memory in rats after a stroke.

Hair follicle stem cell exosomes help nerve regeneration.

Targeting specific GABA receptors may help treat epilepsy and postpartum depression.

Higher CRHR1 levels in AA patients lead to increased inflammation.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

The method accurately measures hormones and endocannabinoids in mice, showing gut microbiota diversity affects these levels and may influence stress and reproductive systems.

Targeting neurosteroids may help prevent drug relapse.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Neuropeptides affect hair growth, with some speeding it up and others slowing it down.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Different species have unique sensory adaptations to perceive their environments.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

MicroRNAs are crucial for controlling skin development and healing by regulating genes.

The transcription factor Meis2 is essential for touch sensation and proper nerve development in touch receptors.